
Mohammed A. Hasan
Examiner (ID: 8846, Phone: (571)272-2331 , Office: P/2872 )
| Most Active Art Unit | 2872 |
| Art Unit(s) | 2872, 2873 |
| Total Applications | 2762 |
| Issued Applications | 2490 |
| Pending Applications | 110 |
| Abandoned Applications | 202 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20517620
[patent_doc_number] => 20260041723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-12
[patent_title] => BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 19/309246
[patent_app_country] => US
[patent_app_date] => 2025-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19309246
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/309246 | BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION | Aug 24, 2025 | Pending |
Array
(
[id] => 19657003
[patent_doc_number] => 20240424068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
[patent_app_type] => utility
[patent_app_number] => 18/755419
[patent_app_country] => US
[patent_app_date] => 2024-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755419
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/755419 | USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION | Jun 25, 2024 | Pending |
Array
(
[id] => 19691266
[patent_doc_number] => 20250009811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/748761
[patent_app_country] => US
[patent_app_date] => 2024-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18748761
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/748761 | COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS | Jun 19, 2024 | Pending |
Array
(
[id] => 19402282
[patent_doc_number] => 20240285793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/657338
[patent_app_country] => US
[patent_app_date] => 2024-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657338
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657338 | TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY | May 6, 2024 | Abandoned |
Array
(
[id] => 20214499
[patent_doc_number] => 12411145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Methods for quantifying frataxin activity
[patent_app_type] => utility
[patent_app_number] => 18/637707
[patent_app_country] => US
[patent_app_date] => 2024-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14630
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637707
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/637707 | Methods for quantifying frataxin activity | Apr 16, 2024 | Issued |
Array
(
[id] => 19447334
[patent_doc_number] => 20240307464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA
[patent_app_type] => utility
[patent_app_number] => 18/627241
[patent_app_country] => US
[patent_app_date] => 2024-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/627241 | Spore-based probiotic supplementation in dogs and control of endotoxemia | Apr 3, 2024 | Issued |
Array
(
[id] => 19752801
[patent_doc_number] => 20250041366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/602659
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602659
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/602659 | BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS | Mar 11, 2024 | Pending |
Array
(
[id] => 19263635
[patent_doc_number] => 20240207332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => EDIBLE PLANT PARTS ENRICHED WITH PROBIOTIC BACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/594570
[patent_app_country] => US
[patent_app_date] => 2024-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18594570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/594570 | Edible plant parts enriched with probiotic bacteria | Mar 3, 2024 | Issued |
Array
(
[id] => 19510571
[patent_doc_number] => 20240342257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/592050
[patent_app_country] => US
[patent_app_date] => 2024-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18592050
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/592050 | BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE | Feb 28, 2024 | Pending |
Array
(
[id] => 19140464
[patent_doc_number] => 20240139252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => TREATMENT OF VON WILLEBRAND DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/406008
[patent_app_country] => US
[patent_app_date] => 2024-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/406008 | Treatment of von Willebrand disease | Jan 4, 2024 | Issued |
Array
(
[id] => 18970448
[patent_doc_number] => 20240050540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE
[patent_app_type] => utility
[patent_app_number] => 18/492533
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492533
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492533 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | Oct 22, 2023 | Abandoned |
Array
(
[id] => 18970404
[patent_doc_number] => 20240050496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => PROBIOTIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/490629
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490629
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/490629 | PROBIOTIC COMPOSITION | Oct 18, 2023 | Abandoned |
Array
(
[id] => 19065679
[patent_doc_number] => 20240100105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 18/481324
[patent_app_country] => US
[patent_app_date] => 2023-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18481324
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/481324 | BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS | Oct 4, 2023 | Abandoned |
Array
(
[id] => 18806121
[patent_doc_number] => 20230380450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => PASTURE TREATMENTS FOR ENHANCED CARBON SEQUESTRATION AND REDUCTION IN LIVESTOCK-PRODUCED GREENHOUSE GAS EMISSIONS
[patent_app_type] => utility
[patent_app_number] => 18/448915
[patent_app_country] => US
[patent_app_date] => 2023-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448915
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/448915 | PASTURE TREATMENTS FOR ENHANCED CARBON SEQUESTRATION AND REDUCTION IN LIVESTOCK-PRODUCED GREENHOUSE GAS EMISSIONS | Aug 11, 2023 | Pending |
Array
(
[id] => 18806954
[patent_doc_number] => 20230381287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE
[patent_app_type] => utility
[patent_app_number] => 18/231982
[patent_app_country] => US
[patent_app_date] => 2023-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18231982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/231982 | FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE | Aug 8, 2023 | Pending |
Array
(
[id] => 18877503
[patent_doc_number] => 20240000872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 18/351961
[patent_app_country] => US
[patent_app_date] => 2023-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351961 | NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS | Jul 12, 2023 | Abandoned |
Array
(
[id] => 19120028
[patent_doc_number] => 11963989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs
[patent_app_type] => utility
[patent_app_number] => 18/336973
[patent_app_country] => US
[patent_app_date] => 2023-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 5142
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18336973
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/336973 | Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs | Jun 16, 2023 | Issued |
Array
(
[id] => 18784780
[patent_doc_number] => 20230372412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => DYSOSMOBACTER, A NOVEL BACTERIAL GENUS OF THE GASTROINSTESTINAL MICROBIOTA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/317309
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317309
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317309 | None | May 14, 2023 | Issued |
Array
(
[id] => 19417394
[patent_doc_number] => 20240293517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => Chimeric endolysin polypeptide, cluster 3b
[patent_app_type] => utility
[patent_app_number] => 18/314864
[patent_app_country] => US
[patent_app_date] => 2023-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/314864 | Chimeric endolysin polypeptide, cluster 3b | May 9, 2023 | Issued |
Array
(
[id] => 18550789
[patent_doc_number] => 20230248789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => THERAPEUTIC BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/301188
[patent_app_country] => US
[patent_app_date] => 2023-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301188
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301188 | Therapeutic bacteriophage compositions for treating | Apr 13, 2023 | Issued |